Zevra Therapeutics Inc. (NASDAQ: ZVRA)
$9.6400
+0.0550 ( -0.10% ) 264.2K
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With unique, data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.